250 related articles for article (PubMed ID: 23811283)
1. Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.
Kim MC; Lee JS; Kwon YM; O E; Lee YJ; Choi JG; Wang BZ; Compans RW; Kang SM
Antiviral Res; 2013 Sep; 99(3):328-35. PubMed ID: 23811283
[TBL] [Abstract][Full Text] [Related]
2. Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.
Kim MC; Song JM; O E; Kwon YM; Lee YJ; Compans RW; Kang SM
Mol Ther; 2013 Feb; 21(2):485-92. PubMed ID: 23247101
[TBL] [Abstract][Full Text] [Related]
3. Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.
Lee YN; Kim MC; Lee YT; Hwang HS; Lee J; Kim C; Kang SM
PLoS One; 2015; 10(9):e0137822. PubMed ID: 26366729
[TBL] [Abstract][Full Text] [Related]
4. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.
Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM
Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203
[TBL] [Abstract][Full Text] [Related]
5. Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.
Kim MC; Lee YN; Hwang HS; Lee YT; Ko EJ; Jung YJ; Cho MK; Kim YJ; Lee JS; Ha SH; Kang SM
Vaccine; 2014 Oct; 32(44):5824-31. PubMed ID: 25171841
[TBL] [Abstract][Full Text] [Related]
6. Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens.
Song BM; Kang HM; Lee EK; Jung SC; Kim MC; Lee YN; Kang SM; Lee YJ
Vaccine; 2016 Jan; 34(5):678-686. PubMed ID: 26691568
[TBL] [Abstract][Full Text] [Related]
7. Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.
Lee YN; Lee YT; Kim MC; Hwang HS; Lee JS; Kim KH; Kang SM
Immunology; 2014 Oct; 143(2):300-9. PubMed ID: 24773389
[TBL] [Abstract][Full Text] [Related]
8. Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.
Music N; Reber AJ; Kim MC; York IA; Kang SM
Vaccine; 2016 Jan; 34(4):466-473. PubMed ID: 26709639
[TBL] [Abstract][Full Text] [Related]
9. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
[TBL] [Abstract][Full Text] [Related]
10. An influenza A virus vaccine based on an M2e-modified alphavirus.
Krishnavajhala HR; Williams J; Heidner H
Arch Virol; 2018 Feb; 163(2):483-488. PubMed ID: 29079954
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
Shim BS; Choi YK; Yun CH; Lee EG; Jeon YS; Park SM; Cheon IS; Joo DH; Cho CH; Song MS; Seo SU; Byun YH; Park HJ; Poo H; Seong BL; Kim JO; Nguyen HH; Stadler K; Kim DW; Hong KJ; Czerkinsky C; Song MK
PLoS One; 2011; 6(11):e27953. PubMed ID: 22140491
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
Lee YT; Kim KH; Ko EJ; Kim MC; Lee YN; Hwang HS; Lee Y; Jung YJ; Kim YJ; Santos J; Perez DR; Kang SM
Virology; 2019 Mar; 529():111-121. PubMed ID: 30685658
[TBL] [Abstract][Full Text] [Related]
13. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
14. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.
Zharikova D; Mozdzanowska K; Feng J; Zhang M; Gerhard W
J Virol; 2005 Jun; 79(11):6644-54. PubMed ID: 15890902
[TBL] [Abstract][Full Text] [Related]
15. Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.
Kim YJ; Ko EJ; Kim MC; Lee YN; Kim KH; Jung YJ; Kang SM
Biochem Biophys Res Commun; 2017 Nov; 493(1):393-398. PubMed ID: 28887040
[TBL] [Abstract][Full Text] [Related]
16. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
Wang W; Huang B; Wang X; Tan W; Ruan L
Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
[TBL] [Abstract][Full Text] [Related]
17. Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
Kim KH; Kwon YM; Lee YT; Hwang HS; Kim MC; Ko EJ; Wang BZ; Quan FS; Kang SM
Virology; 2018 Nov; 524():172-181. PubMed ID: 30199754
[TBL] [Abstract][Full Text] [Related]
18. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.
Park BR; Subbiah J; Kim KH; Kwon YM; Oh J; Kim MC; Shin CH; Seong BL; Kang SM
Virology; 2022 Jan; 566():143-152. PubMed ID: 34929590
[TBL] [Abstract][Full Text] [Related]
20. Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.
Kim YJ; Lee YT; Kim MC; Lee YN; Kim KH; Ko EJ; Song JM; Kang SM
Front Immunol; 2017; 8():1730. PubMed ID: 29276514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]